Recombinant Human CASP7 Protein，His

CASP7, or Caspase-7, is a cysteine protease that plays a crucial role in the execution phase of apoptosis, the programmed cell death process. As a member of the caspase family, CASP7 is involved in the cleavage of various substrates, leading to cellular differentiation, inflammation, and apoptosis. Its activation is a key event in apoptotic signaling pathways and has been linked to various diseases, including cancer, neurodegenerative disorders, and autoimmune conditions. The study of CASP7 recombinant protein is significant for understanding its functional mechanisms and regulatory pathways in apoptosis. Researchers aim to produce recombinant CASP7 in heterologous systems to study its enzymatic activity, substrate specificity, and interactions with other apoptotic regulators. This knowledge is critical for developing therapeutic strategies targeting apoptosis dysregulation in diseases. Additionally, elucidating the structural properties of CASP7 through recombinant expression can aid in drug design and the discovery of selective inhibitors that may have potential applications in cancer treatment. The growing interest in apoptosis as a therapeutic target underscores the importance of CASP7 research, as understanding its role in cellular processes can lead to innovative cancer therapies and interventions for other apoptosis-related diseases.